Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 251, Issue -, Pages 108549
Publisher
Elsevier BV
Online
2023-10-24
DOI
10.1016/j.pharmthera.2023.108549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
- (2023) Zobair M. Younossi et al. HEPATOLOGY
- Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target
- (2023) Khanyisani Ziqubu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity surgery: Which procedure should we choose and why?
- (2023) P. Topart Journal of Visceral Surgery
- Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
- (2023) Ornella Verrastro et al. LANCET
- Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
- (2023) Rohit Loomba et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
- (2023) Sean Wharton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
- (2023) Rohit Loomba et al. Lancet Gastroenterology & Hepatology
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- (2023) W Timothy Garvey et al. LANCET
- Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2023) Filip K Knop et al. LANCET
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
- (2023) Julio Rosenstock et al. LANCET
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- (2023) Mikhail N. Kosiborod et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
- (2023) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The GIPR is Predominantly Localized to Non-Adipocyte Cell Types Within White Adipose Tissue
- (2022) Jonathan E. Campbell et al. DIABETES
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
- (2022) Domenica M. Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
- (2022) Dragana Nikolic et al. Diabetes Therapy
- Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
- (2022) Victoria E. R. Parker et al. DIABETES OBESITY & METABOLISM
- Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
- (2022) Sophie L van Veldhuisen et al. EUROPEAN HEART JOURNAL
- Obesity and gut–microbiota–brain axis: A narrative review
- (2022) Arezoo Asadi et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Microbiota medicine: towards clinical revolution
- (2022) Prisca Gebrayel et al. Journal of Translational Medicine
- Calorie Restriction with or without Time-Restricted Eating in Weight Loss
- (2022) Deying Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
- (2022) Takashi Kadowaki et al. Lancet Diabetes & Endocrinology
- Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
- (2022) Stergios A. Polyzos et al. Current Obesity Reports
- Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice
- (2022) Beatriz Aviles Bueno et al. Clinical Kidney Journal
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome
- (2022) Mohamad Khalil et al. Nutrients
- AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
- (2022) Eduardo Grunvald et al. GASTROENTEROLOGY
- LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
- (2022) Shweta Urva et al. LANCET
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study
- (2022) Ulrich Dischinger et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program
- (2022) Carel W. le Roux et al. Obesity
- Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
- (2022) Bin Yang et al. Molecular Metabolism
- The Microbiota-Gut-Brain Axis: From Motility to Mood
- (2021) Kara G. Margolis et al. GASTROENTEROLOGY
- Effectiveness of liraglutide 3 mg for the treatment of obesity in a real-world setting without intensive lifestyle intervention
- (2021) Jung Ha Park et al. INTERNATIONAL JOURNAL OF OBESITY
- Cellular and molecular pathobiology of heart failure with preserved ejection fraction
- (2021) Sumita Mishra et al. Nature Reviews Cardiology
- Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages
- (2021) Yawei Wang et al. Nature Communications
- Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial
- (2021) Tricia M.‐M. Tan et al. DIABETES OBESITY & METABOLISM
- How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
- (2021) Yana Geng et al. Hepatology International
- The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease
- (2021) S. R. Bornstein et al. HORMONE AND METABOLIC RESEARCH
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Metformin for Obesity: A Systematic Review
- (2021) Reem Masarwa et al. PEDIATRICS
- From Systemic Inflammation to Myocardial Fibrosis
- (2021) Walter J. Paulus et al. CIRCULATION RESEARCH
- Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
- (2021) Rajaa Nahra et al. DIABETES CARE
- Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD ‐11
- (2021) Enzo Bonora et al. DIABETES OBESITY & METABOLISM
- An Update on the Epidemiology of Type 2 Diabetes
- (2021) Maria G. Tinajero et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- GDF15 and Cardiac Cells: Current Concepts and New Insights
- (2021) Luc Rochette et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- Does Modern Lifestyle Favor Neuroimmunometabolic Changes? A Path to Obesity
- (2021) Camila Guazzelli Marques et al. Frontiers in Nutrition
- Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging
- (2021) Anne Flint et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction
- (2021) Matthew K. Burrage et al. CIRCULATION
- Exercise-Mediated Browning of White Adipose Tissue: Its Significance, Mechanism and Effectiveness
- (2021) Wang-Jing Mu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019
- (2021) Pegah Golabi et al. JOURNAL OF HEPATOLOGY
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
- (2021) Michael E. Nassif et al. NATURE MEDICINE
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- COVID-19 and metabolic disease: mechanisms and clinical management
- (2021) Charlotte Steenblock et al. Lancet Diabetes & Endocrinology
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- UCP1-independent thermogenesis
- (2020) Anna Roesler et al. BIOCHEMICAL JOURNAL
- Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium
- (2020) Matthew A. Caporizzo et al. CIRCULATION
- Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
- (2020) W. Timothy Garvey et al. DIABETES CARE
- Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
- (2020) Thomas A. Wadden et al. Obesity
- Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis
- (2020) Joanna Góralska et al. Nutrients
- Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass
- (2020) Kathleen M. McTigue et al. JAMA Surgery
- Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
- (2020) Benedetta Maria Bonora et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Myocardial Energetics in Obesity
- (2020) Jennifer J. Rayner et al. CIRCULATION
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- Profile of the gut microbiota of adults with obesity: a systematic review
- (2020) Louise Crovesy et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice
- (2020) Stephanie J. Alexopoulos et al. Nature Communications
- BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control
- (2020) Christopher L Axelrod et al. EMBO Molecular Medicine
- FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes
- (2020) Gema Frühbeck et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
- (2020) Leiluo Geng et al. Nature Reviews Endocrinology
- Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis
- (2020) Tom Wiggins et al. PLOS MEDICINE
- Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
- (2020) Lena M.S. Carlsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- GDF15, an update of the physiological and pathological roles it plays: a review
- (2020) Artin Assadi et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
- (2020) Xiling Lin et al. Scientific Reports
- Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity
- (2020) Tatsuo Kawai et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
- (2020) Luc Rochette et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth differentiation factor 15 as a potential therapeutic for treating obesity
- (2020) Clarence Hale et al. Molecular Metabolism
- Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction
- (2019) Qutuba G. Karwi et al. Cardiovascular Diabetology
- PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
- (2019) Claudia Guida et al. EBioMedicine
- Weight Loss Enhances Cardiac Energy Metabolism and Function in Heart Failure Associated with Obesity
- (2019) Qutuba G Karwi et al. DIABETES OBESITY & METABOLISM
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
- (2019) Preeshila Behary et al. DIABETES CARE
- Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist
- (2019) Victoria E R Parker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of GIP in α-cells and glucagon secretion
- (2019) Kimberley El et al. PEPTIDES
- Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
- (2019) Teresa Salvatore et al. Nutrients
- An evaluation of liraglutide including its efficacy and safety for the treatment of obesity
- (2019) Chen-Hsiu Lin et al. EXPERT OPINION ON PHARMACOTHERAPY
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Incretin hormones: Their role in health and disease
- (2018) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- The Science of Obesity Management: An Endocrine Society Scientific Statement
- (2018) George A Bray et al. ENDOCRINE REVIEWS
- New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
- (2018) Nahum Mendez-Sanchez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Current understanding of the human microbiome
- (2018) Jack A Gilbert et al. NATURE MEDICINE
- The Origin and Understanding of the Incretin Concept
- (2018) Jens F. Rehfeld Frontiers in Endocrinology
- Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity
- (2018) Sadiya S. Khan et al. JAMA Cardiology
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- The Role of Neuropeptide Y in Cardiovascular Health and Disease
- (2018) Cheryl M. J. Tan et al. Frontiers in Physiology
- GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner
- (2018) Yanqing Zhang et al. DIABETES
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of adipose tissue in cardiovascular health and disease
- (2018) Evangelos K. Oikonomou et al. Nature Reviews Cardiology
- Acceleration of BMI in Early Childhood and Risk of Sustained Obesity
- (2018) Mandy Geserick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial
- (2018) Thomas A. Wadden et al. Obesity
- Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
- (2018) Piotr A. Mroz et al. Molecular Metabolism
- Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
- (2017) Caroline E Geisler et al. JOURNAL OF ENDOCRINOLOGY
- GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
- (2017) Shannon E Mullican et al. NATURE MEDICINE
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction
- (2017) Deana Mikhalkova et al. Obesity
- Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation
- (2017) G.A. Bray et al. Obesity Reviews
- Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
- (2017) Robert E. Steinert et al. PHYSIOLOGICAL REVIEWS
- GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation
- (2017) Rodrigo Carlessi et al. Scientific Reports
- Meta-Analysis of Short Sleep Duration and Obesity in Children and Adults
- (2017) Francesco P. Cappuccio et al. SLEEP
- GLP-1 and weight loss: unraveling the diverse neural circuitry
- (2016) Scott E. Kanoski et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Adipocyte lipolysis and insulin resistance
- (2016) Pauline Morigny et al. BIOCHIMIE
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
- (2016) Jennifer H. Stern et al. Cell Metabolism
- Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models
- (2016) Munenori Hiromura et al. CIRCULATION JOURNAL
- Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
- (2016) Shilpa N. Bhupathiraju et al. CIRCULATION RESEARCH
- GLP-1 as a target for therapeutic intervention
- (2016) Surya Panicker Rajeev et al. CURRENT OPINION IN PHARMACOLOGY
- Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction
- (2016) Barry A. Borlaug et al. EUROPEAN HEART JOURNAL
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
- (2016) Jaemin Lee et al. NATURE MEDICINE
- The Human Intestinal Microbiome in Health and Disease
- (2016) Susan V. Lynch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies
- (2016) L. Li et al. Obesity Reviews
- Internal Hernia Following Laparoscopic Roux-en-Y Gastric Bypass: Prevention and Tips for Intra-operative Management
- (2016) Abdelrahman A. Nimeri et al. OBESITY SURGERY
- Food Intake and Changes in Eating Behavior After Laparoscopic Sleeve Gastrectomy
- (2016) Ilenia Coluzzi et al. OBESITY SURGERY
- Complications of bariatric surgery: Presentation and emergency management
- (2016) Radwan Kassir et al. International Journal of Surgery
- Bariatric Surgery and Long-term Durability of Weight Loss
- (2016) Matthew L. Maciejewski et al. JAMA Surgery
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity
- (2015) Huei-Fen Jheng et al. Annals of the New York Academy of Sciences
- Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
- (2015) A H Sparre-Ulrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Treatment of Obesity with Celastrol
- (2015) Junli Liu et al. CELL
- Metabolic reprogramming in macrophages and dendritic cells in innate immunity
- (2015) Beth Kelly et al. CELL RESEARCH
- Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
- (2015) Ian J Neeland et al. Diabetes & Vascular Disease Research
- Peripheral Mechanisms in Appetite Regulation
- (2015) Michael Camilleri GASTROENTEROLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in the treatment of type 2 diabetes: evidence to date
- (2015) Jay Shubrook et al. Drug Design Development and Therapy
- Fecal microbiota transplantation: in perspective
- (2015) Shaan Gupta et al. Therapeutic Advances in Gastroenterology
- Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review
- (2014) Lara L Roberson et al. BMC PUBLIC HEALTH
- β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors
- (2014) Lee D. Roberts et al. Cell Metabolism
- Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents
- (2014) J. L. Trevaskis et al. DIABETES OBESITY & METABOLISM
- Corticotropin-Releasing Hormone and the Sympathoadrenal System Are Major Mediators in the Effects of Peripherally Administered Exendin-4 on the Hypothalamic-Pituitary-Adrenal Axis of Male Rats
- (2014) Manuel Gil-Lozano et al. ENDOCRINOLOGY
- GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
- (2013) C. Clemmensen et al. DIABETES
- Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle
- (2013) Tizhong Shan et al. FASEB JOURNAL
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Pharmacological approaches to restore mitochondrial function
- (2013) Pénélope A. Andreux et al. NATURE REVIEWS DRUG DISCOVERY
- Administration of the Y2 Receptor Agonist PYY3-36 in Mice Induces Multiple Behavioral Changes Relevant to Schizophrenia
- (2013) Ulrike Stadlbauer et al. NEUROPSYCHOPHARMACOLOGY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Chronic adipose tissue inflammation: all immune cells on the stage
- (2013) Gökhan Cildir et al. TRENDS IN MOLECULAR MEDICINE
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- Brain-gut-adipose-tissue communication pathways at a glance
- (2012) C.-X. Yi et al. Disease Models & Mechanisms
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short communication: Expression of peptide YY, proglucagon, neuropeptide Y receptor Y2, and glucagon-like peptide-1 receptor in bovine peripheral tissues
- (2012) A. Pezeshki et al. JOURNAL OF DAIRY SCIENCE
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y
- (2011) Evelin Painsipp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression of Neuropeptide Y, Substance P, and Their Receptors in the Right Atrium of Diabetic Patients
- (2011) Asma Ejaz et al. CTS-Clinical and Translational Science
- Emerging GLP-1 receptor agonists
- (2011) Asger Lund et al. EXPERT OPINION ON EMERGING DRUGS
- Fatty Acids Suppress Autophagic Turnover in β-Cells
- (2011) Guy Las et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thirty-day Mortality After Bariatric Surgery: Independently Adjudicated Causes of Death in the Longitudinal Assessment of Bariatric Surgery
- (2011) Mark D. Smith et al. OBESITY SURGERY
- Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)
- (2011) I. Kimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin Resistance in Nonalcoholic Fatty Liver Disease
- (2010) E. Bugianesi et al. CURRENT PHARMACEUTICAL DESIGN
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Body-Mass Index and Mortality among 1.46 Million White Adults
- (2010) Amy Berrington de Gonzalez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACTH-independent macronodular adrenal hyperplasia
- (2009) André Lacroix BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Obesity induces functional astrocytic leptin receptors in hypothalamus
- (2009) H. Hsuchou et al. BRAIN
- Progressive Postnatal Motoneuron Loss in Mice Lacking GDF-15
- (2009) J. Strelau et al. JOURNAL OF NEUROSCIENCE
- Top-Down Systems Biology Modeling of Host Metabotype−Microbiome Associations in Obese Rodents
- (2009) Alison Waldram et al. JOURNAL OF PROTEOME RESEARCH
- Gut Microbiota and Its Possible Relationship With Obesity
- (2009) John K. DiBaise et al. MAYO CLINIC PROCEEDINGS
- Incretin-based therapies for type 2 diabetes mellitus
- (2009) Julie A. Lovshin et al. Nature Reviews Endocrinology
- Brown Adipose Tissue — When It Pays to Be Inefficient
- (2009) Francesco S. Celi NEW ENGLAND JOURNAL OF MEDICINE
- Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats
- (2008) Suraj Unniappan et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Identification and Characterization of Metabolically Benign Obesity in Humans
- (2008) Norbert Stefan ARCHIVES OF INTERNAL MEDICINE
- The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering
- (2008) Rachel P. Wildman ARCHIVES OF INTERNAL MEDICINE
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Changes in gut hormones after bariatric surgery
- (2008) R. P. Vincent et al. CLINICAL ENDOCRINOLOGY
- The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
- (2008) Artemis P. Simopoulos EXPERIMENTAL BIOLOGY AND MEDICINE
- Central Control of Body Weight and Appetite
- (2008) Stephen C. Woods et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
- (2008) Iris Shai et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started